2019

Highlights from the July 2019 Issue

July 1, 2019 // 0 Comments

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers [read more...]

Muscle Relaxant Use in Dialysis

June 17, 2019 // 0 Comments

Most practicing nephrologists have seen cases of baclofen toxicity in patients on dialysis; in severe cases, this can even mimic brain death. Some nephrologists on Twitter (eg @Nephro_Sparks) have taken up the call to educate clinicians about the [read more...]

Clinical Trial End Points in ADPKD

June 6, 2019 // 0 Comments

Despite our current understanding regarding the pathophysiology of autosomal dominant polycystic kidney disease (ADPKD), only one therapy has been approved by the US FDA. There has been recent interest in redefining end points for clinical trials [read more...]

Highlights from the June 2019 Issue

June 3, 2019 // 0 Comments

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers [read more...]

Congo Red: From Amyloid to Aspirin

May 29, 2019 // 1 Comment

Congo red is synonymous with amyloidosis. The visually stunning apple green birefringence lights up the eyes and minds of pathologists and nephrologists. Like many histological stains, Congo red was originally a textile dye that was later used to [read more...]